List of SBIR/STTR awards granted to Transcendent International, LLC
Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase I contract was awarded to Transcendent International, LLC in September, 2021 for $207,432.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44NR020320-01A1 | Phase I | 207,432 | September 22, 2021 | |||||||
A SBIR Phase II contract was awarded to Transcendent International, LLC in August, 2019 for $670,032.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44NR016908-02 | Phase II | 670,032 | August 29, 2019 | |||||||
A SBIR Phase I contract was awarded to Transcendent International, LLC in July, 2019 for $223,676.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43DA049495-01 | Phase I | 223,676 | July 1, 2019 | |||||||
A SBIR Phase I contract was awarded to Transcendent International, LLC in August, 2018 for $207,995.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44NR016908-01A1 | Phase I | 207,995 | August 1, 2018 | |||||||
A SBIR Phase I contract was awarded to Transcendent International, LLC in June, 2020 for $231,500.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44GM137681-01 | Phase I | 231,500 | June 1, 2020 | |||||||
A SBIR Phase II contract was awarded to Transcendent International, LLC in August, 2021 for $776,388.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44GM137681-02 | Phase II | 776,388 | August 1, 2021 | |||||||
A SBIR Phase I contract was awarded to Transcendent International, LLC in September, 2022 for $265,832.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44MD018266-01 | Phase I | 265,832 | September 26, 2022 | |||||||
A SBIR Phase I contract was awarded to Transcendent International, LLC in June, 2022 for $292,201.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44MD017552-01 | Phase I | 292,201 | June 1, 2022 | |||||||
A SBIR Phase II contract was awarded to Transcendent International, LLC in February, 2017 for $1,148,591.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44MD010402-02 | Phase II | 1,148,591 | February 1, 2017 | |||||||
A SBIR Phase I contract was awarded to Transcendent International, LLC in August, 2016 for $225,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44MD010402-01A1 | Phase I | 225,000 | August 10, 2016 | |||||||
A SBIR Phase II contract was awarded to Transcendent International, LLC in April, 2014 for $1,724,898.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44MD008672-01 | Phase II | 1,724,898 | April 8, 2014 | |||||||
A SBIR Phase II contract was awarded to Transcendent International, LLC in March, 2016 for $1,195,687.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44MD010522-02 | Phase II | 1,195,687 | March 1, 2016 | |||||||
A SBIR Phase II contract was awarded to Transcendent International, LLC in May, 2013 for $1,158,633.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44MD007635-02 | Phase II | 1,158,633 | May 1, 2013 | |||||||
A SBIR Phase II contract was awarded to Transcendent International, LLC in September, 2015 for $1,200,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44MD009581-02 | Phase II | 1,200,000 | September 9, 2015 | |||||||
A SBIR Phase I contract was awarded to Transcendent International, LLC in September, 2017 for $216,565.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43HD092164-01 | Phase I | 216,565 | September 13, 2017 | |||||||
A SBIR Phase I contract was awarded to Transcendent International, LLC in September, 2015 for $199,344.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44MD010522-01A1 | Phase I | 199,344 | September 2, 2015 | |||||||
A SBIR Phase I contract was awarded to Transcendent International, LLC for $241,701.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43TR000361-01 | Phase I | 241,701 | ||||||||
A SBIR Phase II contract was awarded to Transcendent International, LLC for $1,286,787.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44MD006166-02 | Phase II | 1,286,787 | ||||||||
A SBIR Phase II contract was awarded to Transcendent International, LLC for $1,873,130.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44HD054080-02 | Phase II | 1,873,130 | ||||||||
A SBIR Phase II contract was awarded to Transcendent International, LLC for $2,494,372.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44CA150534-02 | Phase II | 2,494,372 | ||||||||
A SBIR Phase I contract was awarded to Transcendent International, LLC for $98,400.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43LM007908-01A1 | Phase I | 98,400 | ||||||||
A SBIR Phase II contract was awarded to Transcendent International, LLC for $1,242,560.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44DK083839-02 | Phase II | 1,242,560 | ||||||||
A SBIR Phase I contract was awarded to Transcendent International, LLC for $98,943.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA121796-01 | Phase I | 98,943 | ||||||||
A SBIR Phase II contract was awarded to Transcendent International, LLC for $663,916.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44CA121796-02 | Phase II | 663,916 | ||||||||
A SBIR Phase II contract was awarded to Transcendent International, LLC for $1,924,468.0 USD from the U.S. Department of Health & Human Services. | SBIR | 4R44HD071679-02 | Phase II | 1,924,468 |
